Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

PBYI

PUMA BIOTECHNOLOGY, INC.

CIK 0001401667 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$7.90
↓ 0.23 (-2.83%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options

Key stats

Market Cap
$402.11M
P/E Ratio
16.49
EPS
0.62
Dividend Yield
Not covered
52W Position
90%
Beta
0.57

Valuation multiples

Fwd P/E
7.97
PEG
0.03
P/B
3.13
P/S
1.77
EV/Revenue
1.66
ROE
19.0%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 90%
$3.03$8.44

Latest Financials

2025-12-31 FY
Revenue
$228.37M
Net Income
$31.11M
Total Assets
$216.30M
Free Cash Flow
$41.73M

Recent news